Catalyst Wire Dossier Catalyst Wire Dossier

Phosphatidylserine-Omega-3

phosphatidylserine omega-3 fatty acid combination · Enzymotec
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Phosphatidylserine-Omega-3, covering 2009-11-25 to 2010-03-24. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment [Phase 4]

See pricing